Pegcetacoplan Registrational Programs Begun for C3G, ALS, and IC-MPGN
Photo by Robina Weermeijer on Unsplash

Pegcetacoplan Registrational Programs Begun for C3G, ALS, and IC-MPGN

  According to a press release, biopharmaceutical company Apellis Pharmaceuticals ("Apellis") recently launched registration programs to explore pegcetacoplan for patients with C3 glomerulopathy (C3G), amyotrophic lateral sclerosis (ALS), and immune…

Continue Reading Pegcetacoplan Registrational Programs Begun for C3G, ALS, and IC-MPGN
This Glomerulonephritis Patient has Been Receiving Dialysis Treatment for Over 30 Years. Now he Shares his Discipline with Other Patients
source: pixabay.com

This Glomerulonephritis Patient has Been Receiving Dialysis Treatment for Over 30 Years. Now he Shares his Discipline with Other Patients

  According to a recent article in the MalayMail, it occurred to Abdullah’s doctor that the 67-year-old would be an inspiration for others who have kidney failure. His nephrologist, Dr.…

Continue Reading This Glomerulonephritis Patient has Been Receiving Dialysis Treatment for Over 30 Years. Now he Shares his Discipline with Other Patients

Paroxysmal Nocturnal Hemoglobinuria Investigative Therapy Moving to Phase 3 Trial in 2020

The EMA has just announced that Danicopan has been accepted into its PRIority MEdicines (PRIME) program. Danicopan is being developed for paroxysmal nocturnal hemoglobinuria (PNH), a rare blood condition. PRIME…

Continue Reading Paroxysmal Nocturnal Hemoglobinuria Investigative Therapy Moving to Phase 3 Trial in 2020

A New Potential Drug Target for Inflammatory Diseases such as Ulcerative Colitis Discovered

Claudia Stäubert and her team of researchers at the University of Leipzig have just reported noteworthy findings which could impact the future treatment of inflammatory diseases. Lactic acid bacteria, or…

Continue Reading A New Potential Drug Target for Inflammatory Diseases such as Ulcerative Colitis Discovered
New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis
Source: Pixabay.com

New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis

According to a story from bioportfolio.com, two companies, Ionis Pharmaceuticals, Inc., and its affiliate Akcea Pharmaceuticals, recently announced that its product inotersen (to be marketed as TEGSEDI) has gained approval…

Continue Reading New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis
Looking for Romantic Gift Ideas? This Woman Gave Her Soul Mate Her Kidney
Source: Pixabay

Looking for Romantic Gift Ideas? This Woman Gave Her Soul Mate Her Kidney

It was a classic story of boy-on-dialysis-waiting-for-a-kidney-transplant meets girl. The year was 1997. Larry Wetsch's kidneys were in dire state, hardening due to a rare disease called glomerulonephritis. Glomerulonephritis happens when…

Continue Reading Looking for Romantic Gift Ideas? This Woman Gave Her Soul Mate Her Kidney
Close Menu